Norbert W. Bischofberger
Chief Executive Officer bij KRONOS BIO, INC.
Vermogen: 10 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Norbert W. Bischofberger
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 151 | |
61
| Public Company | Pharmaceuticals: Major | 61 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
56
| Subsidiary | Biotechnology | 56 |
Swiss Federal Institute of Technology
45
| College/University | Other Consumer Services | 45 |
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Pharmaceuticals: Major | 21 | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA.
17
| Subsidiary | Biotechnology | 17 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts.
15
| Private Company | Investment Managers | 15 |
University of Innsbruck
11
| College/University | Other Consumer Services | 11 |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Norbert W. Bischofberger via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Biotechnology | President Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HENKEL AG & CO. KGAA | Household/Personal Care | Chairman Director/Board Member | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman Private Equity Investor | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA. | Investment Managers | Founder Chief Executive Officer | |
Henkel Management AG
 Henkel Management AG Miscellaneous Commercial ServicesCommercial Services Part of Henkel AG & Co. KGaA, Henkel Management AG is a German company that provides management services. The private company is based in Dusseldorf, Germany. The company was founded in 2008. Carsten Knobel has been the CEO of the company since 1995. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Founder Founder Chief Executive Officer Private Equity Investor Investor Relations Contact Corporate Secretary Private Equity Investor | |
| Berkeley Law University of California | College/University | Graduate Degree Graduate Degree | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Biotechnology | Director/Board Member Director/Board Member | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Founder Director/Board Member Founder | |
| NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The private company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder General Counsel Founder | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member Chairman Director/Board Member | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
Breakthrough Properties Growth Portfolio I LP
 Breakthrough Properties Growth Portfolio I LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP functions as a pooled investment and private equity fund. The private company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 42 |
| Duitsland | 4 |
| Verenigd Koninkrijk | 3 |
| Hongkong | 2 |
| China | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 669 |
| Corporate Officer/Principal | 229 |
| Independent Dir/Board Member | 155 |
| Chairman | 84 |
| Undergraduate Degree | 72 |
Sterkste connecties
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Amir Nashat | 49 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Martin Edwards | 38 |
| Otello Stampacchia | 37 |
| Helen Kim | 33 |
| George Scangos | 33 |
| Étienne Francois Davignon | 31 |
| Nilesh Kumar | 26 |
| David Tanen | 25 |
| Tiba Aynechi | 24 |
| Simeon George | 23 |
| Horst Heinz Paul Baier | 23 |
| Gregg Alton | 22 |
- Beurs
- Insiders
- Norbert W. Bischofberger
- Bedrijfsconnecties
